Pamela Reilly Contag, PhD

Pamela R. Contag, PhD, has founded four early stage technology companies, most recently ConcentRx, a cell-based immune therapy company and Cygnet Inc. commercializing a platform technology to discover beneficial microbes for applications in food, renewable fuels, low cost therapeutics, industrial enzymes, and carbon dioxide capture. With more than 25 years of microbiology research experience, Dr. Contag is widely published in the field of Microbiology and Optical imaging and has over 35 patents in Biotechnology. Dr. Contag received her Ph.D. in Microbiology.